Literature DB >> 19275877

Potentiation of angiogenesis and regeneration by G-CSF after sciatic nerve crush injury.

Hung-Chuan Pan1, Hsi-Tien Wu, Fu-Chou Cheng, Cheng-Hsu Chen, Meei-Ling Sheu, Chun-Jung Chen.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) demonstrates neuroprotective effects through different mechanisms, including mobilization of bone marrow cells. However, the influence of G-CSF-mediated mobilization of bone marrow-derived cells on injured sciatic nerves remains to be elucidated. The administration of G-CSF promoted a short-term functional recovery 7 days after crush injury in sciatic nerves. A double-immunofluorescence study using green fluorescent protein-chimeric mice revealed that bone marrow-derived CD34+ cells were predominantly mobilized and migrated into injured nerves after G-CSF treatment. G-CSF-mediated beneficial effects against sciatic nerve injury were associated with increased CD34+ cell deposition, vascular endothelial growth factor (VEGF) expression, and vascularization/angiogenesis as well as decreased CD68+ cell accumulation. However, cell differentiation and VEGF expression were not demonstrated in deposited cells. The results suggest that the promotion of short-term functional recovery in sciatic nerve crush injury by G-CSF involves a paracrine modulatory effect and a bone marrow-derived CD34+ cell mobilizing effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275877     DOI: 10.1016/j.bbrc.2009.03.003

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  The Effects of Granulocyte-Colony Stimulating Factor on Regeneration in Nerve Crush Injuries in Rats.

Authors:  Yi-Sun Song; Jun-Ho Joe; Hyun-Woo Joo; In-Hwa Park; Guang-Yin Shen; Ki-Jun Kim; Yonggu Lee; Jeong Hun Shin; Hyuck Kim; Kyung-Soo Kim
Journal:  Neurochem Res       Date:  2016-03-15       Impact factor: 3.996

2.  CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.

Authors:  Alexandre Henriques; Claudia Pitzer; Tanjew Dittgen; Matthias Klugmann; Luc Dupuis; Armin Schneider
Journal:  Mol Ther       Date:  2010-12-07       Impact factor: 11.454

3.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

4.  A novel combinatorial therapy with pulp stem cells and granulocyte colony-stimulating factor for total pulp regeneration.

Authors:  Koichiro Iohara; Masashi Murakami; Norio Takeuchi; Yohei Osako; Masataka Ito; Ryo Ishizaka; Shinji Utunomiya; Hiroshi Nakamura; Kenji Matsushita; Misako Nakashima
Journal:  Stem Cells Transl Med       Date:  2013-06-12       Impact factor: 6.940

Review 5.  A Cell-Based Approach to Dental Pulp Regeneration Using Mesenchymal Stem Cells: A Scoping Review.

Authors:  Sahng G Kim
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  Effect of granulocyte colony-stimulating factor on the peripheral nerves in streptozotocin-induced diabetic rat.

Authors:  Kyung Ae Lee; Kyung Taek Park; Hea Min Yu; Heung Yong Jin; Hong Sun Baek; Tae Sun Park
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

7.  Seawater immersion aggravates sciatic nerve injury in rats.

Authors:  Haifeng Wang; Jian Fang; Feng Hu; Gewei Li; H E Hong
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

8.  Effect of melatonin supplemented at the light or dark period on recovery of sciatic nerve injury in rats.

Authors:  Enas Ezzat Rateb; Shaimaa Nasr Amin; Nashwa El-Tablawy; Laila Ahmed Rashed; Samah El-Attar
Journal:  EXCLI J       Date:  2017-03-06       Impact factor: 4.068

9.  Increased angiogenesis by the rotational muscle flap is crucial for nerve regeneration.

Authors:  Hung-Chuan Pan; Ming-Hong Chang; Meei-Ling Sheu; Chun-Jung Chen; Jason Sheehan
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.